Daniel Filip

Brno, JM, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Follicular Lymphoma Transformation is Characterized by Cytokine-associated Remodeling of Stromal and Macrophage Compartments.

Follicular Lymphoma Transformation is Characterized by Cytokine-associated Remodeling of Stromal and Macrophage Compartments.

Journal: Cancer discovery

Published: July 21, 2025

Repression of miR-29 via MYC leads to increased CD40 signaling in transformed follicular lymphoma.

Repression of miR-29 via MYC leads to increased CD40 signaling in transformed follicular lymphoma.

Journal: Leukemia

Published: July 03, 2025

Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drugs.

Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drugs.

Journal: Leukemia

Published: March 11, 2024

Transformation of indolent follicular lymphoma into diffuse large B-cell lymphoma - the molecular basis of "cancer aggressiveness".

Transformation of indolent follicular lymphoma into diffuse large B-cell lymphoma - the molecular basis of "cancer aggressiveness".

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: October 25, 2023

FoxO1/Rictor axis induces a nongenetic adaptation to ibrutinib via Akt activation in chronic lymphocytic leukemia.

FoxO1/Rictor axis induces a nongenetic adaptation to ibrutinib via Akt activation in chronic lymphocytic leukemia.

Journal: The Journal of clinical investigation

Published: July 11, 2023

STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma.

STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma.

Journal: Leukemia

Published: April 07, 2020

miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors.

miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors.

Journal: Blood

Published: March 11, 2020

The role of MYC in the transformation and aggressiveness of 'indolent' B-cell malignancies.

The role of MYC in the transformation and aggressiveness of 'indolent' B-cell malignancies.

Journal: Leukemia & lymphoma

Published: October 22, 2019

Showing 1-8 of 8

Last Updated: 09/26/2026